IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v75y2012i12p2143-2150.html
   My bibliography  Save this article

Vaccine innovation, translational research and the management of knowledge accumulation

Author

Listed:
  • Yaqub, Ohid
  • Nightingale, Paul

Abstract

What does it take to translate research into socially beneficial technologies like vaccines? Current policy that focuses on expanding research or strengthening incentives overlooks how the supply and demand of innovation is mediated by problem-solving processes that generate knowledge which is often fragmented and only locally valid. This paper details some of the conditions that allow fragmented, local knowledge to accumulate through a series of structured steps from the artificial simplicity of the laboratory to the complexity of real world application. Poliomyelitis is used as an illustrative case to highlight the importance of experimental animal models and the extent of co-ordination that can be required if they are missing. Implications for the governance and management of current attempts to produce vaccines for HIV, TB and Malaria are discussed.

Suggested Citation

  • Yaqub, Ohid & Nightingale, Paul, 2012. "Vaccine innovation, translational research and the management of knowledge accumulation," Social Science & Medicine, Elsevier, vol. 75(12), pages 2143-2150.
  • Handle: RePEc:eee:socmed:v:75:y:2012:i:12:p:2143-2150
    DOI: 10.1016/j.socscimed.2012.07.023
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953612005643
    Download Restriction: Full text for ScienceDirect subscribers only

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Nichter, Mark, 1995. "Vaccinations in the third world: A consideration of community demand," Social Science & Medicine, Elsevier, vol. 41(5), pages 617-632, September.
    2. Blume, Stuart & Tump, Janneke, 2010. "Evidence and policymaking: The introduction of MMR vaccine in the Netherlands," Social Science & Medicine, Elsevier, vol. 71(6), pages 1049-1055, September.
    3. Richard R. Nelson, 2008. "Factors affecting the power of technological paradigms," Industrial and Corporate Change, Oxford University Press, vol. 17(3), pages 485-497, June.
    4. Dosi, Giovanni, 1993. "Technological paradigms and technological trajectories : A suggested interpretation of the determinants and directions of technical change," Research Policy, Elsevier, vol. 22(2), pages 102-103, April.
    5. Bastien, Joseph W., 1995. "Cross cultural communication of tetanus vaccinations in Bolivia," Social Science & Medicine, Elsevier, vol. 41(1), pages 77-86, July.
    6. Poltorak, Mike & Leach, Melissa & Fairhead, James & Cassell, Jackie, 2005. "'MMR talk' and vaccination choices: An ethnographic study in Brighton," Social Science & Medicine, Elsevier, vol. 61(3), pages 709-719, August.
    7. Bonu, Sekhar & Rani, Manju & Baker, Timothy D., 2003. "The impact of the national polio immunization campaign on levels and equity in immunization coverage: evidence from rural North India," Social Science & Medicine, Elsevier, vol. 57(10), pages 1807-1819, November.
    8. Blume, Stuart, 2006. "Anti-vaccination movements and their interpretations," Social Science & Medicine, Elsevier, vol. 62(3), pages 628-642, February.
    9. Archibugi, Daniele & Bizzarri, Kim, 2004. "Committing to vaccine R&D: a global science policy priority," Research Policy, Elsevier, vol. 33(10), pages 1657-1671, December.
    10. Jean O. Lanjouw, 2003. "Intellectual Property and the Availability of Pharmaceuticals in Poor Countries," NBER Chapters,in: Innovation Policy and the Economy, Volume 3, pages 91-130 National Bureau of Economic Research, Inc.
    11. Nelson, Richard R. & Buterbaugh, Kristin & Perl, Marcel & Gelijns, Annetine, 2011. "How medical know-how progresses," Research Policy, Elsevier, vol. 40(10), pages 1339-1344.
    12. Nightingale, Paul, 2004. "Technological capabilities, invisible infrastructure and the un-social construction of predictability: the overlooked fixed costs of useful research," Research Policy, Elsevier, vol. 33(9), pages 1259-1284, November.
    13. Blume, Stuart S., 2005. "Lock in, the state and vaccine development: Lessons from the history of the polio vaccines," Research Policy, Elsevier, vol. 34(2), pages 159-173, March.
    14. Mays, Rose M. & Sturm, Lynne A. & Zimet, Gregory D., 2004. "Parental perspectives on vaccinating children against sexually transmitted infections," Social Science & Medicine, Elsevier, vol. 58(7), pages 1405-1413, April.
    15. Bryder, Linda, 1999. "'We shall not find salvation in inoculation': BCG vaccination in Scandinavia, Britain and the USA, 1921-1960," Social Science & Medicine, Elsevier, vol. 49(9), pages 1157-1167, November.
    16. Blume, Stuart & Zanders, Mariska, 2006. "Vaccine independence, local competences and globalisation: Lessons from the history of pertussis vaccines," Social Science & Medicine, Elsevier, vol. 63(7), pages 1825-1835, October.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Paul Nightingale, 2014. "What is technology? Six definitions and two pathologies," SPRU Working Paper Series 2014-19, SPRU - Science and Technology Policy Research, University of Sussex.
    2. Yaqub, Ohid & Castle-Clarke, Sophie & Sevdalis, Nick & Chataway, Joanna, 2014. "Attitudes to vaccination: A critical review," Social Science & Medicine, Elsevier, vol. 112(C), pages 1-11.
    3. Polzin, Friedemann & von Flotow, Paschen & Klerkx, Laurens, 2016. "Addressing barriers to eco-innovation: Exploring the finance mobilisation functions of institutional innovation intermediaries," Technological Forecasting and Social Change, Elsevier, vol. 103(C), pages 34-46.
    4. repec:oup:indcch:v:27:y:2018:i:1:p:173-187. is not listed on IDEAS
    5. Matthew L. Wallace & Ismael Rafols, 2016. "Shaping the Agenda of a Grand Challenge: Institutional Mediation of Priorities in Avian Influenza Research," SPRU Working Paper Series 2016-02, SPRU - Science and Technology Policy Research, University of Sussex.
    6. Yaqub, Ohid, 2017. "Testing regimes in clinical trials: Evidence from four polio vaccine trajectories," Research Policy, Elsevier, vol. 46(2), pages 475-484.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:75:y:2012:i:12:p:2143-2150. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.